Yes, 3 OMPs: tolvaptan for autosomal dominant polycystic kidney disease, Alpha 1-antitrypsin for Alpha1-antitrypsin deficiency and eliglustat for Gaucher disease. Here, SERPINA1 is linked to autosomal dominant polycystic kidney disease.